2014
Genetic Predisposition to Dyslipidemia and Risk of Preeclampsia
Spracklen CN, Saftlas AF, Triche EW, Bjonnes A, Keating B, Saxena R, Breheny PJ, Dewan AT, Robinson JG, Hoh J, Ryckman KK. Genetic Predisposition to Dyslipidemia and Risk of Preeclampsia. American Journal Of Hypertension 2014, 28: 915-923. PMID: 25523295, PMCID: PMC4542907, DOI: 10.1093/ajh/hpu242.Peer-Reviewed Original ResearchMeSH KeywordsAdultBiomarkersBlood PressureCase-Control StudiesChi-Square DistributionCholesterol, HDLCholesterol, LDLDyslipidemiasFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansIowaLogistic ModelsMultivariate AnalysisOdds RatioPhenotypePolymorphism, Single NucleotidePre-EclampsiaPregnancyRisk FactorsTriglyceridesYoung Adult
2006
Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction
Grosso LM, Triche EW, Belanger K, Benowitz NL, Holford TR, Bracken MB. Caffeine Metabolites in Umbilical Cord Blood, Cytochrome P-450 1A2 Activity, and Intrauterine Growth Restriction. American Journal Of Epidemiology 2006, 163: 1035-1041. PMID: 16641310, DOI: 10.1093/aje/kwj125.Peer-Reviewed Original ResearchConceptsIntrauterine growth restrictionRisk of IUGRUmbilical cord bloodGrowth restrictionCord bloodCaffeine consumptionRatio of paraxanthineCytochrome PSelf-reported caffeine consumptionPreterm deliveryFetal exposureHighest quartileAdjusted analysisPregnant womenFetal growthObstetric practiceCYP1A2 activityParaxanthine levelsReproductive outcomesAdjusted modelAssociation of caffeineCaffeine metabolitesStandard deviation changeConflicting resultsQuartile